Impact of the UK lockdown on people at risk of COPD

• Gavin C. Donaldson,
• Andrew I. Ritchie,
• Peter M.A. Calverley,
• Jorgen Vestbo,
• Malin Fageras,
• Alberto de la Hoz,
• Enrica Bucchioni,
• Chris H. Compton,
• Karen Mezzi,
• Jadwiga A. Wedzicha

Affiliations

Gavin C. Donaldson

National Heart and Lung Institute, Imperial College London, London, UK

Andrew I. Ritchie

National Heart and Lung Institute, Imperial College London, London, UK

Peter M.A. Calverley

University Hospital Aintree, University of Liverpool, Liverpool, UK

Jorgen Vestbo

Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK

Malin Fageras

Astra-Zeneca, Gothenburg, Sweden

Alberto de la Hoz

Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany

Enrica Bucchioni

Chiesi, Parma, Italy

Chris H. Compton

GSK, Brentford, UK

Karen Mezzi

Novartis Pharma AG, Basel, Switzerland

Jadwiga A. Wedzicha

National Heart and Lung Institute, Imperial College London, London, UK